Article
Genome-wide meta-analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans.
Molecular genetics & genomic medicine - 1 Oct 2019
Do Anh N, Zhao Wei, Baldridge Abigail S, Raffield Laura M, Wiggins Kerri L, Shah Sanjiv J, Aslibekyan Stella, Tiwari Hemant K, Limdi Nita, Zhi Degui, Sitlani Colleen M, Taylor Kent D, Psaty Bruce M, Sotoodehnia Nona, Brody Jennifer A, Rasmussen-Torvik Laura J, Lloyd-Jones Donald, Lange Leslie A, Wilson James G, Smith Jennifer A, Kardia Sharon L R, Mosley Thomas H, Vasan Ramachandran S, Arnett Donna K, Irvin Marguerite R
Abstract excerpt
BACKGROUND: Left ventricular (LV) hypertrophy affects up to 43% of African Americans (AAs). Antihypertensive treatment reduces LV mass (LVM). However, interindividual variation in LV traits in response to antihypertensive treatments exists. We hypothesized that genetic variants may modify the association of antihypertensive treatment class with LV traits measured by echocardiography. METHODS: We evaluated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
